Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Lovastatin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

44 API Suppliers, 30 USDMF, 12 CEP/COS, 1 JDMF, 3 EU WC, 2 KDMF, 9 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

98 FDF Dossiers, 37 FDA Orange Book, 49 Europe, 4 Canada, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 20MG, TABLET, EXTENDED RELEASE;ORAL - 40MG, TABLET, EXTENDED RELEASE;ORAL - 60MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 6 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 29 BASF, 2 CD Formulation, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 24 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 13 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 30 Direct Compression, 30 Thickeners and Stabilizers, 29 Granulation, 26 Solubilizers, 26 Controlled & Modified Release, 20 Topical, 18 Lubricants & Glidants, 18 Disintegrants & Superdisintegrants, 17 Film Formers & Plasticizers, 16 Parenteral, 11 Co-Processed Excipients, 10 Emulsifying Agents, 10 Taste Masking, 8 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 7 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 33 Regulatory FDF Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

12 Health Canada Patents

12 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 12 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 2000-406 - Rev 06	Lovastatin	2025-07-08	Valid	Chemical		1538
31/10/2025	Alembic Pharmaceuticals Limited	India	ALEMBIC LIMITED Vadodara IN	R0-CEP 2014-083 - Rev 00	Lovastatin	2015-11-13	Withdrawn by Holder	Chemical	2017-06-19	1538

Lovastatin

Lovastatin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

44 API Suppliers

30 USDMF

12 CEP/COS

1 JDMF

3 EU WC

2 KDMF

9 NDC API

11 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

98 FDF Dossiers

37 FDA Orange Book

49 Europe

4 Canada

2 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 20MG

TABLET, EXTENDED RELEASE;ORAL - 40MG

TABLET, EXTENDED RELEASE;ORAL - 60MG

RELATED EXCIPIENT COMPANIES

1 Evonik

4 SPI Pharma

6 DKSH

1 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Pfanstiehl

5 Kirsch Pharma

1 ACG Worldwide

8 Actylis

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

29 BASF

2 CD Formulation

1 Clariant

10 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

4 Ideal Cures

3 Ingredion Pharma Solutions

24 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

19 Roquette

13 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

1 Valens Pharmachem

3 Vasa Pharmachem

1 Vertellus

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 20MG Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 40MG Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons